开放性放射性核素治疗后患者免住院的建议(ICRP 94报告要点解读)

Release of patients therapy with unsealed radionuclides(ICRP publication 94)

国际辐射防护委员会(ICRP)94号报告建议开放性放射性核素治疗后患者可免住院,对个体患者做具体分析后作出住院与否的决定,不应仅根据估算的体内残留量一律要求住院。ICRP 94号报告以高端科研为基础,分析比较了住院与免住院的利弊。临床医师在实际工作中,应该对ICRP 94号报告正确理解,把现行实际情况与管理规划统一到ICRP 94号报告的实质中,以便在实践中很好地执行。

The decision to hospitalize or release patients should be determined on an individual basis and should not be based solely on their residual activity according to ICRP publication 94.Based on high-end scientific research,ICRP publication 94 analyzed and compared the advantages and disadvantages of hospitalization and non-hospitalization.To help scientific studies weigh the pros and cons of hospitalization and release,this report aims to achieve a uniform understanding and practical implementation of these practices.